The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee - Scorecard - MDSpire

The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee

  • November 5, 2025

  • 0 min

Share

Clinical Scorecard: The 51st Annual Conference of the European Society for Blood and Marrow Transplantation: Organizing Committee Details

At a Glance

CategoryDetail
ConditionBlood and marrow transplantation and related hematologic conditions
Key MechanismsScientific collaboration and research dissemination in hematopoietic stem cell transplantation
Target PopulationPatients requiring blood and marrow transplantation and related therapies
Care SettingSpecialized transplant centers and hematology research institutions

Key Highlights

  • The conference is a hybrid meeting held from 30 March to 2 April 2025.
  • Organized by the European Society for Blood and Marrow Transplantation (EBMT) with a comprehensive scientific and nursing committee.
  • Focus on multiple working parties covering acute leukemia, aplastic anemia, autoimmune diseases, chronic malignancies, cellular therapy, infectious diseases, transplant complications, lymphoma, and pediatric diseases.

Guideline-Based Recommendations

Diagnosis

  • Utilize multidisciplinary expert input from working parties specializing in specific hematologic conditions.

Management

  • Incorporate latest evidence and consensus from EBMT working parties for transplant and post-transplant care.

Monitoring & Follow-up

  • Engage quality management and data management groups to ensure rigorous outcome tracking and quality assurance.

Risks

  • Address transplant complications through dedicated working party expertise.

Patient & Prescribing Data

Patients undergoing blood and marrow transplantation for various hematologic diseases.

Treatment approaches are informed by multidisciplinary expert committees and ongoing research presented at EBMT annual meetings.

Clinical Best Practices

  • Engage specialized working parties for disease-specific transplant protocols.
  • Involve nursing leadership and pharmacists in comprehensive care planning.
  • Utilize data and quality management groups to optimize patient outcomes.

References

Original Source(s)

The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee

  • November 5, 2025

Related Content

A comprehensive review and expression analysis of polymorphisms in DNA repair genes linked to leukemia

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

  • by

  • December 17, 2025

  • 4 min
Smarter Digital Morphology Triage

A diffusion-based approach aims to handle domain shifts, slide variability, and rare cell appearances

  • January 30, 2026

  • 3 min